G Gregoriadis. Show Affiliations »
Abstract
Mesh: See more » Adjuvants, ImmunologicAdministration, OralAnimalsAntineoplastic Agents/administration & dosageCytarabine/administration & dosageCytarabine/metabolismGaucher Disease/drug therapyGlucosidases/administration & dosageHumansLeukemia L1210/drug therapyPharmaceutical VehiclesPhospholipids/toxicitybeta-Glucosidase/administration & dosagebeta-Glucosidase/therapeutic use
Substances: See more » Adjuvants, ImmunologicAntineoplastic AgentsPharmaceutical VehiclesPhospholipidsCytarabineGlucosidasesbeta-Glucosidase
Year: 1978 PMID: 100040 DOI: 10.1111/j.1749-6632.1978.tb22034.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691